Skip to content
Catalyst

3-methyl-1-hydroxybutylthiamine diphosphatePapers

Measures 3-methyl-1-hydroxybutylthiamine diphosphate as an outcome

paper
1
1 year, by papers

Newest first

1 to 1 of 1
  • Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study.

    Journal of ovarian research2019PMID 30904021

Every paper about 3-methyl-1-hydroxybutylthiamine diphosphate